A Case of a Pneumocystis Pneumonia Twenty-four Years After Living Kidney Transplantation Due to Withdrawal of Sulfamethoxazole/Trimethoprim Prophylaxis

被引：1
|
作者：
Kono, Momoko [1 ]
Kojima, Kaori [1 ]
Wakai, Sachiko [1 ]
Shirakawa, Hiroki [2 ]
机构：
[1] Okubo Hosp, Tokyo Metropolitan Hlth & Med Treatment Corp, Dept Nephrol, Shinjuku Ku, 2-44-1 Kabukicho, Tokyo 1608488, Japan
[2] Okubo Hosp, Tokyo Metropolitan Hlth & Med Treatment Corp, Dept Urol, Shinjuku Ku, Tokyo, Japan
来源：
TRANSPLANTATION DIRECT | 2018年 / 4卷 / 06期
关键词：
D O I：
10.1097/TXD.0000000000000796
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页数：2
相关论文
共 42 条
  • [21] Effectiveness and Safety Evaluation of Thrice Weekly Double Strength vs Daily Single Strength Trimethoprim-Sulfamethoxazole for Prophylaxis of Pneumocystis Jirovecii Pneumonia after Kidney Transplantation: A Two-Year Prospective Cohort Study
    Yang, Hui
    Pang, Lizhen
    Hu, Xiaopeng
    Wang, Wei
    Xu, Bifang
    Zhang, Xiaodong
    Liu, Lihong
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2021, 24 : 220 - 226
  • [22] Hypercalcemia and Pneumocystis pneumonia after kidney transplantation: report of an exceptional case and literature review
    Chatzikyrkou, C.
    Clajus, C.
    Haubitz, M.
    Hafer, C.
    TRANSPLANT INFECTIOUS DISEASE, 2011, 13 (05) : 496 - 500
  • [23] A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation
    Colby, C
    McAfee, SL
    Sackstein, R
    Finkelstein, DM
    Fishman, JA
    Spitzer, TR
    BONE MARROW TRANSPLANTATION, 1999, 24 (08) : 897 - 902
  • [24] A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation
    C Colby
    SL McAfee
    R Sackstein
    DM Finkelstein
    JA Fishman
    TR Spitzer
    Bone Marrow Transplantation, 1999, 24 : 897 - 902
  • [25] Pulmonary complications after bone marrow transplantation in children:: Twenty-four years of experience in a single pediatric center
    Griese, M
    Rampf, U
    Hofmann, D
    Führer, M
    Reinhardt, D
    Bender-Götze, C
    PEDIATRIC PULMONOLOGY, 2000, 30 (05) : 393 - 401
  • [26] Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study
    Chen, Ruo-Yang
    Li, Da-Wei
    Wang, Jie-Ying
    Zhuang, Shao-Yong
    Wu, Hao-Yu
    Wu, Jia-Jin
    Qu, Jun-Wen
    Sun, Nan
    Zhong, Chen
    Zhu, Cheng
    Zhang, Ming
    Yu, Yue-Tian
    Yuan, Xiao-Dong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 125 : 209 - 215
  • [27] Comparison of caspofungin and trimethoprim-sulfamethoxazole combination therapy with standard monotherapy in patients with Pneumocystis jiroveci pneumonia following kidney transplantation: a retrospective analysis of 22 cases
    Yu, Bo
    Yang, Yu
    Ye, Linyang
    Xie, Xiaowei
    Guo, Jiaxiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 1234 - 1242
  • [28] Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study
    Chen, Ruo-Yang
    Li, Da -Wei
    Wang, Jie-Ying
    Zhuang, Shao-Yong
    Wu, Hao-Yu
    Wu, Jia-Jin
    Qu, Jun-Wen
    Sun, Nan
    Zhong, Chen
    Zhu, Cheng
    Zhang, Ming
    Yu, Yue-Tian
    Yuan, Xiao-Dong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 125 : 209 - 215
  • [29] Myelotoxicity and kidney dysfunction related to the use of trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia: a case report of severe adverse events with a common drug
    Melo Mendes, Isabel Cristina
    Mamani, Roxana Flores
    Araujo Coelho, David Richer
    Pimentel, Clarisse
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2024, 66
  • [30] ORAL TRIMETHOPRIM-SULFAMETHOXAZOLE (TM-SMX) VS INHALED PENTAMIDINE (P) FOR PREVENTION OF PNEUMOCYSTIS PNEUMONIA (PCP) AFTER RENAL-TRANSPLANTATION
    PEDAGOGOS, E
    NICHOLLS, K
    WILSON, J
    WALKER, R
    BECKER, G
    KIDNEY INTERNATIONAL, 1994, 46 (03) : 922 - 922
12345